Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2
- PMID: 11463386
- DOI: 10.1016/s1097-2765(01)00208-8
Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2
Abstract
The CDK-interacting protein phosphatase KAP dephosphorylates phosphoThr-160 (pThr-160) of the CDK2 activation segment, the site of regulatory phosphorylation that is essential for kinase activity. Here we describe the crystal structure of KAP in association with pThr-160-CDK2, representing an example of a protein phosphatase in complex with its intact protein substrate. The major protein interface between the two molecules is formed by the C-terminal lobe of CDK2 and the C-terminal helix of KAP, regions remote from the kinase-activation segment and the KAP catalytic site. The kinase-activation segment interacts with the catalytic site of KAP almost entirely via the phosphate group of pThr-160. This interaction requires that the activation segment is unfolded and drawn away from the kinase molecule, inducing a conformation of CDK2 similar to the activated state observed in the CDK2/cyclin A complex.
Similar articles
-
Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin.Science. 1995 Oct 6;270(5233):90-3. doi: 10.1126/science.270.5233.90. Science. 1995. PMID: 7569954
-
Picture story. Reining in CDK.Nat Struct Biol. 2001 May;8(5):391. doi: 10.1038/87542. Nat Struct Biol. 2001. PMID: 11323710 No abstract available.
-
Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2.J Biol Chem. 2005 Apr 29;280(17):17235-42. doi: 10.1074/jbc.M413437200. Epub 2005 Jan 24. J Biol Chem. 2005. PMID: 15671017
-
Structuring cell-cycle biology.Structure. 1995 Nov 15;3(11):1131-4. doi: 10.1016/s0969-2126(01)00248-9. Structure. 1995. PMID: 8591023 Review.
-
X-ray crystallographic studies of CDK2, a basis for cyclin-dependent kinase inhibitor design in anti-cancer drug research.Curr Med Chem Anticancer Agents. 2003 Jan;3(1):15-23. doi: 10.2174/1568011033353515. Curr Med Chem Anticancer Agents. 2003. PMID: 12678911 Review.
Cited by
-
Identifying allosteric fluctuation transitions between different protein conformational states as applied to Cyclin Dependent Kinase 2.BMC Bioinformatics. 2007 Feb 7;8:45. doi: 10.1186/1471-2105-8-45. BMC Bioinformatics. 2007. PMID: 17286863 Free PMC article.
-
Biochemical characterization of Cdk2-Speedy/Ringo A2.BMC Biochem. 2005 Sep 28;6:19. doi: 10.1186/1471-2091-6-19. BMC Biochem. 2005. PMID: 16191191 Free PMC article.
-
p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2Cdelta.Biochem J. 2004 Sep 1;382(Pt 2):425-31. doi: 10.1042/BJ20040948. Biochem J. 2004. PMID: 15206906 Free PMC article.
-
A critical evaluation of protein kinase regulation by activation loop autophosphorylation.Elife. 2023 Jul 20;12:e88210. doi: 10.7554/eLife.88210. Elife. 2023. PMID: 37470698 Free PMC article.
-
Polyphony: superposition independent methods for ensemble-based drug discovery.BMC Bioinformatics. 2014 Sep 30;15(1):324. doi: 10.1186/1471-2105-15-324. BMC Bioinformatics. 2014. PMID: 25265915 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
